Nicholas Simon's Net Worth
Estimate Recalculated Nov 11, 2024 07:51AM EST
Who is Nicholas Simon
Nicholas Simon does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include TETRALOGIC PHARMACEUTICALS Corp, , ZOGENIX, INC., Gritstone Oncology, Inc., AERIE PHARMACEUTICALS INC, Ophthotech Corp., Oxford Immunotec Global PLC, Sientra, Inc., Entasis Therapeutics Holdings Inc., Restoration Robotics Inc, Forty Seven, Inc., AVANIR PHARMACEUTICALS, and ACHILLION PHARMACEUTICALS INC.
SEC CIK
Nicholas Simon's CIK is 0001431403
Past Insider Trading and Trends
2019 was Nicholas Simon's most active year for acquiring shares with 2 total transactions. Nicholas Simon's most active month to acquire stocks was the month of May. 2008 was Nicholas Simon's most active year for disposing of shares, totalling 1 transactions. Nicholas Simon's most active month to dispose stocks was the month of July. 2018 saw Nicholas Simon paying a total of $125,011.04 for 6,116 shares, this is the most they've acquired in one year. In 2008 Nicholas Simon cashed out on 25,000 shares for a total of $0.00, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
